Extended indication Leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non‑fami
Therapeutic value Possible equal value
Total cost 35,000,000.00
Registration phase Positive CHMP opinion

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information